Literature DB >> 6330729

Analysis of the transforming potential of the human H-ras gene by random mutagenesis.

O Fasano, T Aldrich, F Tamanoi, E Taparowsky, M Furth, M Wigler.   

Abstract

Some tumor cells contain mutant ras genes that are capable of transforming NIH 3T3 cells. Those genes that have been analyzed arise from the wild-type, non-transforming ras genes by mutations producing single amino acid substitutions at position 12 or 61 of the encoded protein. We have performed random bisulfite-induced mutagenesis on the cloned wild-type human H-ras gene to find if mutations at other positions can activate the transforming potential of that gene. Most mutations are not activating, but mutations that specify single amino acid substitutions at position 12, 13, 59, or 63 of the encoded protein do activate the transforming potential of the H-ras gene. Some, but not all, mutant ras proteins show an altered electrophoretic mobility in NaDodSO4/polyacrylamide gels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330729      PMCID: PMC345357          DOI: 10.1073/pnas.81.13.4008

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells.

Authors:  O Fasano; E Taparowsky; J Fiddes; M Wigler; M Goldfarb
Journal:  J Mol Appl Genet       Date:  1983

2.  Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene.

Authors:  J P McGrath; D J Capon; D H Smith; E Y Chen; P H Seeburg; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

3.  Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.

Authors:  R K Wierenga; W G Hol
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

4.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

5.  New effective method for the synthesis of oligonucleotides via phosphotriester intermediates.

Authors:  V A Efimov; S V Reverdatto; O G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

6.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.

Authors:  E Taparowsky; Y Suard; O Fasano; K Shimizu; M Goldfarb; M Wigler
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

7.  Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue.

Authors:  M R Pincus; J van Renswoude; J B Harford; E H Chang; R P Carty; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Three human transforming genes are related to the viral ras oncogenes.

Authors:  K Shimizu; M Goldfarb; Y Suard; M Perucho; Y Li; T Kamata; J Feramisco; E Stavnezer; J Fogh; M H Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

10.  Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.

Authors:  K Shimizu; D Birnbaum; M A Ruley; O Fasano; Y Suard; L Edlund; E Taparowsky; M Goldfarb; M Wigler
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

View more
  94 in total

1.  The Role of Gln61 in HRas GTP hydrolysis: a quantum mechanics/molecular mechanics study.

Authors:  Fernando Martín-García; Jesús Ignacio Mendieta-Moreno; Eduardo López-Viñas; Paulino Gómez-Puertas; Jesús Mendieta
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

2.  Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.

Authors:  K Brown; A Buchmann; A Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein.

Authors:  P W Brandt-Rauf; M R Pincus; R P Carty; J Lubowsky; M Avitable; H F Kung; J Maizel
Journal:  J Protein Chem       Date:  1989-02

4.  Identification of an intracellular protein that specifically interacts with photoaffinity-labeled oncogenic p21 protein.

Authors:  G Lee; Z A Ronai; M R Pincus; P W Brandt-Rauf; R B Murphy; T M Delohery; S Nishimura; Z Yamaizumi; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

Authors:  Harry H Yoon; David Tougeron; Qian Shi; Steven R Alberts; Michelle R Mahoney; Garth D Nelson; Suresh G Nair; Stephen N Thibodeau; Richard M Goldberg; Daniel J Sargent; Frank A Sinicrope
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

6.  Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity.

Authors:  P Gideon; J John; M Frech; A Lautwein; R Clark; J E Scheffler; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

7.  ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins.

Authors:  D C Fry; S A Kuby; A S Mildvan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.

Authors:  Karen W Gripp; Katia Sol-Church; Patroula Smpokou; Gail E Graham; David A Stevenson; Heather Hanson; David H Viskochil; Laura C Baker; Bridget Russo; Nick Gardner; Deborah L Stabley; Verena Kolbe; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

Review 9.  DNA adducts in experimental cancer research.

Authors:  K Hemminki; A Försti; R Mustonen; K Savela
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  A product of yeast RAS2 gene is a guanine nucleotide binding protein.

Authors:  F Tamanoi; M Walsh; T Kataoka; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.